Stefan H Hohnloser MD, FACC, FESC, FHRSDistinguished Professor, Professor Emeritus of Medicine and Cardiology, J.W. Goethe University, Frankfurt, and Center of Thrombosis and Hemostasis, University of Mainz, Germany
Dr. Hohnloser holds a position as professor of medicine and cardiology at the J. W. Goethe University in Frankfurt, Germany, where he is the head of the division of clinical electrophysiology. His primary research interests focus on risk stratification for and prevention of sudden cardiac death, and pharmacological, antithrombotic, and interventional therapies of atrial fibrillation. Dr. Hohnloser has served as principal investigator or member of the steering committee of many international large randomized clinical trials related to contemporary issues in clinical arrhythmology. He has coauthored over 360 publications in peer-reviewed journals, 450 abstracts and 50 book chapters. Dr. Hohnloser has been or is currently serving on several committees of the European Society of Cardiology and the Heart Rhythm Society.
Recent Contributions to PracticeUpdate:
- Lower Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban vs Warfarin in Patients With AF
- Amiodarone-Associated Optic Neuropathy
- Combined Ranolazine and Dronedarone for Paroxysmal Atrial Fibrillation
- Amiodarone Associated With Increased Thromboembolic Events and Bleeding in Atrial Fibrillation
- Safety of Dronedarone in Routine Clinical Care